FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 203 filers reported holding FIBROGEN INC in Q4 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,952,000 | -21.1% | 71,782 | -22.2% | 1.19% | -27.1% |
| Q2 2020 | $3,741,000 | +16.7% | 92,294 | 0.0% | 1.64% | +16.8% |
| Q1 2020 | $3,207,000 | -19.0% | 92,294 | 0.0% | 1.40% | -26.9% |
| Q4 2019 | $3,958,000 | -24.1% | 92,294 | -34.6% | 1.92% | -32.6% |
| Q3 2019 | $5,216,000 | -26.3% | 141,056 | -10.0% | 2.84% | -41.7% |
| Q2 2019 | $7,081,000 | +140.4% | 156,730 | +189.3% | 4.88% | +139.5% |
| Q1 2019 | $2,945,000 | +5.7% | 54,180 | -10.0% | 2.04% | +24.3% |
| Q4 2018 | $2,786,000 | – | 60,200 | – | 1.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 605,713 | $7,880,000 | 4.60% |
| ARMISTICE CAPITAL, LLC | 4,456,000 | $57,973,000 | 1.01% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $2,489,000 | 0.78% |
| BHK Investment Advisors, LLC | 87,450 | $1,138,000 | 0.57% |
| Soleus Capital Management, L.P. | 234,026 | $3,045,000 | 0.41% |
| Tri Locum Partners LP | 74,348 | $967,000 | 0.26% |
| Point72 Asset Management, L.P. | 4,777,700 | $62,158,000 | 0.25% |
| PRIMECAP MANAGEMENT CO/CA/ | 13,179,897 | $171,470,000 | 0.17% |
| Newbridge Financial Services Group, Inc. | 20,285 | $264,000 | 0.16% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,430,526 | $18,611,000 | 0.15% |